Trial | NCT02338687  Report issue

Title

Low Dose Calcium to Prevent Preeclampsia
Low Dose Calcium Supplementation to Prevent Preeclampsia: a Cluster Randomized Study

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    calcium ...

  • Study Participants

    1040
The purpose of this study is to assess, in pregnant women with calcium-poor diets, what is the effectiveness of low-dose (500 mg/day) calcium supplements associated with an educational intervention, compared to the educational intervention alone, in the prevention of preeclampsia and hypertensive disorders during pregnancy.
Study Started
Oct 31
2014
Primary Completion
Oct 31
2018
Study Completion
Oct 31
2018
Last Update
Oct 12
2023

Dietary Supplement calcium

one chewable tablet daily, at bedtime, containing 500 mg elemental calcium (1250 mg calcium carbonate)

Behavioral Educational sessions

Women will participate in at least 2 interactive group educational sessions lasting 30 minutes each. Session content: importance of calcium during pregnancy and how to modify their diets to include calcium-rich foods that are available locally

  • Other names: Dietary counseling

Education Active Comparator

Educational sessions

Education plus supplement Experimental

Educational sessions and 500 mg calcium per day

Criteria 

Inclusion Criteria:

Capacity to understand verbal and visual instructions
Gestational age 16 - 20 weeks
Live fetus

Exclusion Criteria:

Hyperparathyroidism or other contra-indication to calcium supplementation
Gastrointestinal diseases or conditions that may interfere with calcium absorption (e.g. bariatric surgery, cancer, chronic colitis)
Use of medications that may interfere with calcium absorption (e.g. corticosteroids, thiazides, thyroid hormones)
Women already taking calcium supplements or daily antacids at recruitment
No Results Posted